Literature DB >> 18322718

Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome.

Vasiliki Kostopoulou1, Marinos L Tsiatas, Dimitrios A Kelekis, Meletios-Athanasios Dimopoulos, Christos A Papadimitriou.   

Abstract

Port-a-cath systems are often essential for the administration of long-term chemotherapy in the treatment of malignancies because they improve venous access, but they are associated with complications, mainly thrombosis of central veins. In the present report, we describe a case of right subclavian and superior vena cava port-a-cath-related thrombosis causing superior vena cava syndrome (SVCS) in a patient affected by Hodgkin's disease. The patient underwent percutaneous revascularization with stent positioning, experiencing immediate relief of symptoms. Endovascular procedures for the treatment of nonmalignant SVCS seem to represent a challenging therapeutic option.

Entities:  

Mesh:

Year:  2008        PMID: 18322718     DOI: 10.1007/s10140-008-0714-5

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  13 in total

Review 1.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

2.  Nonmalignant superior vena cava syndrome: pathophysiology and management.

Authors:  Branislav Schifferdecker; James A Shaw; Thomas C Piemonte; Andrew C Eisenhauer
Journal:  Catheter Cardiovasc Interv       Date:  2005-07       Impact factor: 2.692

3.  Repositioning and leaving in situ the central venous catheter during percutaneous treatment of associated superior vena cava syndrome: a report of eight cases.

Authors:  L Stockx; H Raat; J Donck; G Wilms; G Marchal
Journal:  Cardiovasc Intervent Radiol       Date:  1999 May-Jun       Impact factor: 2.740

Review 4.  Superior vena cava syndrome. Experience with endovascular stents and surgical therapy.

Authors:  N Schindler; R L Vogelzang
Journal:  Surg Clin North Am       Date:  1999-06       Impact factor: 2.741

5.  Endovascular stenting of nonmalignant superior vena cava syndrome.

Authors:  M A Sheikh; B B Fernandez; B H Gray; L M Graham; Teresa L Carman
Journal:  Catheter Cardiovasc Interv       Date:  2005-07       Impact factor: 2.692

6.  High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.

Authors:  B Gordon; W Haire; A Kessinger; M Duggan; J Armitage
Journal:  Bone Marrow Transplant       Date:  1991-12       Impact factor: 5.483

7.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Authors:  Alok A Khorana; Charles W Francis; Eva Culakova; Nicole M Kuderer; Gary H Lyman
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

8.  Safety and efficacy of thrombolytic therapy for superior vena cava syndrome.

Authors:  B H Gray; J W Olin; R A Graor; J R Young; J R Bartholomew; W F Ruschhaupt
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

9.  Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports.

Authors:  V Puel; M Caudry; P Le Métayer; J C Baste; D Midy; C Marsault; H Demeaux; J P Maire
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

10.  Complications of indwelling venous access devices in cancer patients.

Authors:  B J Eastridge; A T Lefor
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

View more
  1 in total

1.  Hodgkin Lymphoma-Associated Superior Vena Cava Syndrome: A Case Report and Review of the Literature.

Authors:  Ruoning Ni; Mahmoud Amr; Abhishek Kalla
Journal:  Am J Case Rep       Date:  2021-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.